+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Breast Implants Market Report and Forecast 2024-2032

  • PDF Icon


  • 140 Pages
  • April 2024
  • Region: Global
  • Expert Market Research
  • ID: 5797978
The global breast implants market size was valued at USD 2.60 billion in 2023. It is anticipated to grow at a CAGR of 7.48% during the forecast period of 2024-2032 driven by the increasing prevalence of breast cancer across the globe. It is anticipated to achieve a value of USD 4.9 billion by 2032.

Global Breast Implants Market Overview

Breast implants are medical devices that are used to augment or reconstruct the shape and size of the breasts. They are made of either silicone gel or saline solution and are implanted under the breast tissue or chest muscle. Breast implants are used for cosmetic purposes, such as enhancing the appearance and symmetry of the breasts, or for reconstructive purposes, such as restoring the breast shape after mastectomy, injury, or congenital defects.

The growth of the global breast implants market is driven by several factors, such as the increasing demand for cosmetic breast augmentation, the rising awareness and acceptance of breast implants, the technological advancements and innovations in the products, the improving safety and efficacy of the procedures, and the growing disposable income and medical tourism in emerging markets. However, the market also faces some challenges, such as the high cost of the surgery and implants, the risk of complications and adverse effects, the stringent regulatory requirements and ethical issues, and the social stigma and psychological impact associated with breast implants.

Global Breast Implants Market Analysis

Market Drivers

  • The increasing demand for cosmetic breast augmentation is one of the major drivers of the global breast implants market. According to the International Society of Aesthetic Plastic Surgery (ISAPS), breast augmentation was the most performed cosmetic surgical procedure in the world in 2019, with 1.8 million procedures, accounting for 15.8% of the total cosmetic surgeries. The demand for breast augmentation is fueled by the changing beauty standards, the influence of media and celebrities, the desire to enhance self-esteem and confidence, and the availability of various shapes, sizes, and textures of breast implants.
  • The rising awareness and acceptance of breast implants is another key driver of the market. The awareness and acceptance of breast implants have increased due to the growing number of women who undergo breast implant surgery, the availability of online information and social media platforms, the support from professional associations and patient groups, and the endorsement from celebrities and influencers. The acceptance of breast implants is also reflected in the increasing number of men who undergo breast implant surgery, either for cosmetic or reconstructive reasons.
  • The technological advancements and innovations in the products are also driving the growth of the global breast implants market. The manufacturers of breast implants are constantly developing and launching new products that offer better aesthetic results, safety, durability, and patient satisfaction. Some of the recent innovations in the market include the cohesive gel implants, the anatomical or teardrop-shaped implants, the adjustable implants, the smooth-surface implants, the micro-textured implants, and the fat transfer implants.
  • The improving safety and efficacy of the procedures is another factor that contributes to the growth of the market. The safety and efficacy of the breast implant procedures have improved over the years due to the advancements in the surgical techniques, the use of minimally invasive and endoscopic methods, the adoption of 3D imaging and simulation, the implementation of quality standards and guidelines, and the monitoring and reporting of post-operative outcomes and complications.
  • The growing disposable income and medical tourism in emerging markets are also driving the growth of the global breast implants market. The disposable income and medical tourism in emerging markets, such as China, India, Brazil, Mexico, and Thailand, have increased due to the economic development, the urbanization, the globalization, and the liberalization of the markets. These factors have enabled more people to afford and access breast implant surgery, either in their own countries or in other countries that offer lower costs and higher quality of care.

Market Challenges

  • The high cost of the surgery and implants is one of the major constraints of the global breast implants market. The cost of breast implant surgery varies depending on the type and size of the implant, the surgical technique, the location, the surgeon, and the hospital. According to the American Society of Plastic Surgeons (ASPS), the average cost of breast augmentation surgery in the United States was USD 3,947 in 2019, excluding the cost of the implants, anesthesia, operating room facilities, and other related expenses. The cost of the implants can range from USD 1,000 to USD 3,000, depending on the material, shape, and texture. The high cost of the surgery and implants can deter many potential patients from undergoing the procedure, especially in the developing and underdeveloped regions.
  • The risk of complications and adverse effects is another major constraint of the global breast implants market. The complications and adverse effects of breast implant surgery can include infection, bleeding, hematoma, seroma, capsular contracture, implant rupture or leakage, implant displacement or malposition, implant rippling or wrinkling, breast asymmetry, breast pain, nipple or breast sensation changes, scarring, and need for revision surgery. Some of the rare but serious complications and adverse effects can include anaplastic large cell lymphoma (ALCL), a type of cancer that can develop around the implant, and breast implant illness (BII), a term used to describe a variety of symptoms that can be associated with breast implants, such as fatigue, joint pain, hair loss, cognitive impairment, and autoimmune disorders.
  • The stringent regulatory requirements and ethical issues are also constraining the growth of the global breast implants market. The regulatory requirements and ethical issues of breast implants vary from country to country, depending on the laws, regulations, policies, and standards that govern the approval, marketing, labeling, surveillance, and reporting of the products and procedures. Some of the common regulatory requirements and ethical issues include the minimum age limit for cosmetic breast augmentation, the informed consent and disclosure of risks and benefits, the post-market surveillance and reporting of adverse events, the product recall and withdrawal, and the patient access and affordability.
  • The social stigma and psychological impact associated with breast implants are also limiting the growth of the market. The social stigma and psychological impact associated with breast implants can stem from the negative perceptions, attitudes, and stereotypes that some people may have towards breast implants and the people who undergo breast implant surgery. Some of the common sources of social stigma and psychological impact include cultural and religious beliefs, family and peer pressure, the media and public opinion, and self-image and body dissatisfaction. The social stigma and psychological impact associated with breast implants can affect the mental and emotional well-being of the patients, as well as their social and professional relationships.

Global Breast Implants Market Key Trends

Here are some of the latest market trends for the global breast implants market:

  • Rising Demand for Aesthetic Procedures: There has been a significant increase in the demand for cosmetic surgeries, including breast augmentation procedures, driven by growing beauty and body image consciousness among both women and men.
  • Advancements in Implant Technologies: The market is witnessing continuous advancements in implant materials and technologies, such as the development of highly cohesive silicone gel implants and anatomically shaped implants, offering more natural-looking results and improved safety profiles.
  • Increase in Breast Reconstruction Procedures: A rise in breast cancer incidence rates and greater awareness of reconstructive options have led to an increase in breast reconstruction surgeries, which often involve the use of implants.
  • Growing Popularity of Fat Grafting: Fat grafting or fat transfer breast augmentation is gaining popularity as a more natural alternative to traditional implants, where fat from another part of the patient's body is used to enhance breast size and shape.
  • Shift Towards Customization and Personalization: There is a growing trend towards personalized breast augmentation, where procedures are tailored to meet the individual needs and preferences of the patient, including custom-shaped implants and 3D imaging for pre-surgical planning.
  • Emergence of New Markets: Developing countries are emerging as new markets for breast implants, driven by increasing disposable incomes, growing acceptance of cosmetic procedures, and the expansion of healthcare infrastructure.
  • Regulatory and Safety Concerns: The market continues to be influenced by regulatory actions and safety concerns, such as the scrutiny over certain types of implants due to associations with rare conditions like breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
  • Focus on Post-Surgery Quality of Life: There is an increasing emphasis on the quality of life and long-term satisfaction of patients post-surgery, leading to innovations in implant designs and surgical techniques that focus on minimizing complications and ensuring more durable results.
These trends indicate a dynamic market landscape influenced by technological advancements, changing consumer preferences, and evolving regulatory environments.

Global Breast Implants Market Segmentation

Market Breakup by Material

  • Silicone Gel Implants
  • Saline Implants

Market Breakup by Type

  • Round Breast Implants
  • Anatomical (Teardrop-shaped) Breast Implants

Market Breakup by Application

  • Breast Augmentation
  • Breast Reconstruction

Market Breakup by Incision Site

  • Inframammary Incision
  • Periareolar Incision
  • Transaxillary Incision
  • Transumbilical Incision

Market Breakup by End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Breast Implants Competitor Landscape

The global breast implant market is dominated by a few major players, such as Allergan (Now part of AbbVie), Mentor Worldwide LLC (A Johnson & Johnson Company), Sientra, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sebbin SAS, Groupe Sebbin SAS, Establishment Labs S.A., Silimed, Laboratoires Arion, Hans Biomed Co. Ltd., Guangzhou Wanhe Plastic Materials Co., Ltd., Hologic, Inc. (Cynosure), Ideal Implant Incorporated, and G&G Biotechnology Ltd.

These companies offer a variety of products for cosmetic and reconstructive breast surgery and have strong brand awareness, distribution channels, and innovation capabilities. They also pursue various strategic moves, such as mergers and acquisitions, product launches, partnerships, and collaborations, to maintain their competitive edge and expand their market presence.

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Breast Implant Market Overview
3.1 Global Breast Implant Market Historical Value (2017-2023)
3.2 Global Breast Implant Market Forecast Value (2024-2032)
4 Global Breast Implant Market Landscape
4.1 Global Breast Implant Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Breast Implant Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Breast Implant Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Breast Implant Market Segmentation
6.1 Global Breast Implant Market by Shape
6.1.1 Market Overview
6.1.2 Round Breast Implants
6.1.3 Anatomical Breast Implants
6.2 Global Breast Implant Market by Product Type
6.2.1 Market Overview
6.2.2 Silicone Breast Implant
6.2.3 Saline Breast Implant
6.3 Global Breast Implant Market by Application
6.3.1 Market Overview
6.3.2 Cosmetic Surgery
6.3.3 Reconstructive Surgery
6.4 Global Breast Implant Market by End Use
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Cosmetology Clinics
6.4.4 Ambulatory Surgical Centers
6.5 Global Breast Implant Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Breast Implant Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Breast Implant Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Breast Implant Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Breast Implant Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Breast Implant Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Allergan plc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 CEREPLAS company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 GC Aesthetics PLC
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Sientra Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 POLYTECH Health & Aesthetics GmBH
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Hans Biomed Co., Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medical Devices Business Services, Inc. (Johnson & Johnson)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Groupe Sebbin SAS
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Mentor Worldwide LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Establishment Labs S.A.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Shanghai Kangning Medical Supplies Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Breast Implant Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Allergan plc
  • CEREPLAS company
  • GC Aesthetics PLC
  • Sientra Inc.
  • POLYTECH Health & Aesthetics GmBH
  • Hans Biomed Co. Ltd.
  • Medical Devices Business Services Inc. (Johnson & Johnson)
  • Groupe Sebbin SAS
  • Mentor Worldwide LLC
  • Establishment Labs S.A.
  • Shanghai Kangning Medical Supplies Ltd.